跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26 条关于
“Nanozora”
全部
26
临床试验
10
药物
5
机构
0
资讯
11
上个月
Kaigene Licenses Next-Generation FcRn Inhibitor KG006 to Taisho for Japan in Deal Worth Up to $351 Million
去年
Nanoform Initiates Pivotal Bioequivalence Studies for Nanoenzalutamide Prostate Cancer Treatment
去年
Nanoform Reports Strong Growth and Advances in Nanoparticle Drug Development Pipeline
10个月前
Nanoform Receives European Commercial cGMP License, Advances Multiple Nanoformulated Drug Programs
去年
Cepheid and Oxford Nanopore Partner to Revolutionize Infectious Disease Sequencing Workflows
18天前
Nanopore Sensor Technology Enables Early Detection of Parkinson's and ALS Biomarkers
11个月前
Bio-Techne Expands Oxford Nanopore Partnership Through 2032 for Advanced Genetic Diagnostics
去年
UK Government Partners with Oxford Nanopore to Launch NHS-Wide Pathogen Surveillance System
3个月前
Ultra-Rapid Nanopore Sequencing Reshapes Precision Medicine Across Transplantation, Infectious Disease, and Oncology
6个月前
Oxford Nanopore and Lonza Launch First GMP-Grade Direct RNA Sequencing Solution for mRNA Quality Control
第 1 页,共 2 页
上一页
下一页